The Claim

Exendin-4 is metabolized at different rates in rat kidney and liver tissue homogenates under in vitro conditions, with a half-life of approximately 7.8 minutes in kidney homogenate and 100.9 minutes in liver homogenate, indicating significantly faster degradation in kidney tissue.

Source: In Vitro Metabolic Stability of Exendin-4: Pharmacokinetics and Identification of Cleavage Products

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
8score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Quantitative
1 study reviewed
In plain English

In lab tests with rat tissues, a substance called exendin-4 breaks down way faster in the kidney than in the liver — just a few minutes in the kidney versus over an hour and a half in the liver.

See the scientific wording

In rat kidney and liver tissue homogenates, exendin-4 is metabolized at different rates, with a half-life of approximately 7.8 minutes in kidney homogenate and 100.9 minutes in liver homogenate, indicating significantly faster degradation in kidney tissue under in vitro conditions.

What the research says

1 study
  1. Study: In Vitro Metabolic Stability of Exendin-4: Pharmacokinetics and Identification of Cleavage Products

    The study measured how fast exendin-4 breaks down in rat kidney and liver tissues and found it breaks down much faster in the kidney, just like the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.